Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corina Dota

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|July 27, 2025
Practical guide to concentration-QTc modeling: a hands-on tutorialJoanna Parkinson, Corina Dota, Dinko Rekić
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|November 15, 2002
Computer-based analysis of dynamic QT changes: toward high precision and individual rate correctionCorina Dota, Bo Skallefell, Nils Edvardsson, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 5, 2024
Concentration-QT modeling demonstrates that the selective mineralocorticoid receptor modulator, balcinrenone (AZD9977), does not prolong QT intervalJesper Sundell, Dinko Rekic, Johanna Melin, et al.
Journal of Clinical Pharmacology|February 24, 2021
QT Prolongation Risk Assessment in Oncology: Lessons Learned From Small-Molecule New Drug Applications Approved During 2011-2019Sarit Cohen-Rabbie, Alienor C Berges, Dinko Rekić, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|May 30, 2013
Assessment of ventricular repolarization variability with the DeltaT50 method improves identification of patients with congenital long QT syndromesChristina Abrahamsson, Corina Dota, Bo Skallefell, et al.
Pharmacology Research & Perspectives|October 14, 2025
No Evidence of QTc Interval Prolongation With Baxdrostat Treatment: Concentration-QTc Modeling AssessmentMikael Sunnåker, Christian Källgren, Joanna Parkinson, et al.
Pharmacology Research & Perspectives|March 6, 2024
The myeloperoxidase inhibitor mitiperstat (AZD4831) does not prolong the QT interval at expected therapeutic dosesJoanna Parkinson, Jesper Sundell, Dinko Rekić, et al.
Journal of Clinical Pharmacology|June 9, 2016
Can Bias Evaluation Provide Protection Against False-Negative Results in QT Studies Without a Positive Control Using Exposure-Response Analysis?Georg Ferber, Meijian Zhou, Corina Dota, et al.
Cancer Chemotherapy and Pharmacology|August 25, 2016
Olaparib does not cause clinically relevant QT/QTc interval prolongation in patients with advanced solid tumours: results from two phase I studiesHelen Swaisland, Ruth Plummer, Karen So, et al.
Journal of Electrocardiology|June 28, 2011
DeltaT50--a new method to assess temporal ventricular repolarization variabilityChristina Abrahamsson, Corina Dota, Bo Skallefell, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Pharmacokinetics and Pharmacodynamics|July 27, 2025
Practical guide to concentration-QTc modeling: a hands-on tutorialJoanna Parkinson, Corina Dota, Dinko Rekić
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|November 15, 2002
Computer-based analysis of dynamic QT changes: toward high precision and individual rate correctionCorina Dota, Bo Skallefell, Nils Edvardsson, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 5, 2024
Concentration-QT modeling demonstrates that the selective mineralocorticoid receptor modulator, balcinrenone (AZD9977), does not prolong QT intervalJesper Sundell, Dinko Rekic, Johanna Melin, et al.
Journal of Clinical Pharmacology|February 24, 2021
QT Prolongation Risk Assessment in Oncology: Lessons Learned From Small-Molecule New Drug Applications Approved During 2011-2019Sarit Cohen-Rabbie, Alienor C Berges, Dinko Rekić, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|May 30, 2013
Assessment of ventricular repolarization variability with the DeltaT50 method improves identification of patients with congenital long QT syndromesChristina Abrahamsson, Corina Dota, Bo Skallefell, et al.
Pharmacology Research & Perspectives|October 14, 2025
No Evidence of QTc Interval Prolongation With Baxdrostat Treatment: Concentration-QTc Modeling AssessmentMikael Sunnåker, Christian Källgren, Joanna Parkinson, et al.
Pharmacology Research & Perspectives|March 6, 2024
The myeloperoxidase inhibitor mitiperstat (AZD4831) does not prolong the QT interval at expected therapeutic dosesJoanna Parkinson, Jesper Sundell, Dinko Rekić, et al.
Journal of Clinical Pharmacology|June 9, 2016
Can Bias Evaluation Provide Protection Against False-Negative Results in QT Studies Without a Positive Control Using Exposure-Response Analysis?Georg Ferber, Meijian Zhou, Corina Dota, et al.
Cancer Chemotherapy and Pharmacology|August 25, 2016
Olaparib does not cause clinically relevant QT/QTc interval prolongation in patients with advanced solid tumours: results from two phase I studiesHelen Swaisland, Ruth Plummer, Karen So, et al.
Journal of Electrocardiology|June 28, 2011
DeltaT50--a new method to assess temporal ventricular repolarization variabilityChristina Abrahamsson, Corina Dota, Bo Skallefell, et al.
Pageof 2